D.E. Shaw & Co’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-27,460
| Closed | -$489K | – | 2708 |
|
|
2015
Q1 | $489K | Buy |
27,460
+9,414
| +52% | +$168K | ﹤0.01% | 2070 |
|
|
2014
Q4 | $332K | Buy |
18,046
+9,775
| +118% | +$180K | ﹤0.01% | 2169 |
|
|
2014
Q3 | $200K | Buy |
8,271
+4,715
| +133% | +$114K | ﹤0.01% | 2198 |
|
|
2014
Q2 | $130K | Buy |
+3,556
| New | +$130K | ﹤0.01% | 2249 |
|
|
2014
Q1 | – | Sell |
-4,060
| Closed | -$158K | – | 2505 |
|
|
2013
Q4 | $158K | Sell |
4,060
-14,245
| -78% | -$554K | ﹤0.01% | 2343 |
|
|
2013
Q3 | $829K | Sell |
18,305
-724
| -4% | -$32.8K | ﹤0.01% | 1663 |
|
|
2013
Q2 | $934K | Buy |
+19,029
| New | +$934K | ﹤0.01% | 1540 |
|